Pulmonary arterial hypertension - progress in understanding the disease and prioritizing strategies for drug development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pulmonary arterial hypertension - progress in understanding the disease and prioritizing strategies for drug development

Published:2017-05-19 Issue:2 Volume:282 Page:129-141
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Ghataorhe P.¹,Rhodes C. J.¹,Harbaum L.¹,Attard M.¹,Wharton J.¹,Wilkins M. R.¹^ORCID

Affiliation:

1. Department of Medicine; Imperial College London; London UK

Funder

British Heart Foundation Intermediate Basic Science Research Fellowship

Wellcome Trust - GSK Clinical Fellowship Training Programme

British Heart Foundation Programme

European Respiratory Society fellowship

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/joim.12623/fullpdf

Reference130 articles.

1. A global view of pulmonary hypertension;Hoeper;Lancet Respirat Med,2016

2. Definitions and diagnosis of pulmonary hypertension;Hoeper;J Am Coll Cardiol,2013a

3. Association of borderline pulmonary hypertension with mortality and hospitalization in a large patient cohort: insights from the veterans affairs clinical assessment, reporting, and tracking program;Maron;Circulation,2016

4. Relationship between reactive pulmonary hypertension and mortality in patients with acute decompensated heart failure;Aronson;Circ Heart Fail,2011

5. Focusing on developmental origins and disease inception for the prevention of pulmonary hypertension;Maron;Am J Respir Crit Care Med,2016

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenesis of Pulmonary Arterial Hypertension;Scleroderma;2024

2. Exhaled Air Metabolome Analysis for Pulmonary Arterial Hypertension Fingerprints Identification—The Preliminary Study;International Journal of Environmental Research and Public Health;2022-12-28

3. Integrated Bioinformatic Analysis Reveals TXNRD1 as a Novel Biomarker and Potential Therapeutic Target in Idiopathic Pulmonary Arterial Hypertension;Frontiers in Medicine;2022-05-12

4. An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients;Diagnostics;2022-03-01

5. Commentary: The pressure to treat pulmonary artery hypertension;The Journal of Thoracic and Cardiovascular Surgery;2021-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3